Dueling KRASG12C Inhibitors Achieve Responses

被引：1
|
作者：
Caruso, Catherine
Rose, Suzanne
机构：
来源：
CANCER DISCOVERY | 2020年 / 10卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：10 / 10
页数：1
相关论文
共 50 条
  • [1] KRASG12C inhibitors on the horizon
    Cagir, Ali
    Azmi, Asfar S.
    FUTURE MEDICINAL CHEMISTRY, 2019, 11 (09) : 923 - 925
  • [2] Resistance looms for KRASG12C inhibitors
    Aaron N. Hata
    Alice T. Shaw
    Nature Medicine, 2020, 26 : 169 - 170
  • [3] Resistance looms for KRASG12C inhibitors
    Hata, Aaron N.
    Shaw, Alice T.
    NATURE MEDICINE, 2020, 26 (02) : 169 - 170
  • [4] Mechanisms of Resistance to KRASG12C Inhibitors
    Dunnett-Kane, Victoria
    Nicola, Pantelis
    Blackhall, Fiona
    Lindsay, Colin
    CANCERS, 2021, 13 (01) : 1 - 14
  • [5] Assessment of KRASG12C inhibitors for colorectal cancer
    Piazza, Gary A.
    Chandrasekaran, Preethi
    Maxuitenko, Yulia Y.
    Budhwani, Karim I.
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [6] Evaluation of KRASG12C inhibitor responses in novel murine KRASG12C lung cancer cell line models
    Sisler, Daniel J.
    Hinz, Trista K.
    Le, Anh T.
    Kleczko, Emily K.
    Nemenoff, Raphael A.
    Heasley, Lynn E.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [7] Understanding the basis for acquired resistance to KRASG12C inhibitors
    Santos Ramos, A.
    Gomez Sanchez, D.
    Rico Lopez, S.
    Plaza Exposito, P.
    Paz-Ares, L.
    Ferrer Sanchez, I.
    ANNALS OF ONCOLOGY, 2022, 33 (08) : S1411 - S1411
  • [8] RMC-6291, a next-generation tri-complex KRASG12C(ON) inhibitor, outperforms KRASG12C(OFF) inhibitors in preclinical models of KRASG12C cancers
    Nichols, Robert J.
    Yang, Y. C.
    Cregg, Jim
    Schulze, Chris J.
    Wang, Zhican
    Dua, Richa
    Jiang, Jingjing
    Garrenton, Lindsay S.
    Nasholm, Nicole
    Bermingham, Alun
    Knox, John E.
    Seamon, Kyle
    Longhi, Michael
    Chou, Kang-Jye
    Li, Shaoling
    Wildes, David P.
    Singh, Mallika
    Koltun, Elena S.
    Gill, Adrian L.
    Smith, Jacqueline A. M.
    CANCER RESEARCH, 2022, 82 (12)
  • [9] Discovery of Quinazoline Derivatives as Potent KRASG12C Inhibitors
    Liu, Nian
    Li, Zhilong
    Liu, Rui
    Zhang, Chaoxin
    Sun, Yixiang
    Ma, Xing
    Qin, Qiaohua
    Wu, Tianxiao
    Sun, Yin
    Yin, Wenbo
    Zhang, Haoyu
    Gao, Zixuan
    Xia, Guangxin
    Zhao, Dongmei
    Cheng, Maosheng
    CHEMISTRYSELECT, 2024, 9 (39):
  • [10] Pan-ErbB inhibition enhances activity of KRASG12C inhibitors in preclinical models of KRASG12C mutant cancers
    Robichaux, Jacqulyne P.
    Galan-Cobo, Ana
    Powell, Ried T.
    Gale, Kelly A.
    He, Jun
    Zhang, Fahao
    Nilsson, Monique B.
    Zhang, Xiang
    Sobieski, Mary M.
    Nguyen, Nghi
    Clifford, Stephan C.
    Heymach, John V.
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
12345